Y-Prime Technologies, an Malvern, Penn.-based eClinical products and life sciences consulting services company, has expanded its international operations in Europe and has named Jeanette Anne Greef as senior business analyst in the U.K. office.

Greef has more than 15 years of leadership and management experience within the pharmaceutical industry, specifically regulatory and clinical operations environments, as well as the U.K. health service. Prior to joining Y-Prime, she held various management positions at Medimmune. From 2009-2011, Greef served as director of regulatory and clinical services for Liquent, with full responsibility for all regulatory operation functions in Europe and India.  During her career, she has also held a variety of management positions at TKT/Shire Human Genetic Therapies and Amgen.